CARISA


Also found in: Acronyms.

CARISA

Cardiology A clinical trial–Combination Assessment of Ranolazine In Stable Angina
Mentioned in ?
References in periodicals archive ?
The new analysis zeroed in on the 189 CARISA participants with diabetes.
48% in diabetic CARISA participants on ranolazine 750 mg b.
These data could illustrate an underlying first in class mechanism of action for the statistically significant reductions in HbA1c levels observed with Ranexa in cardiovascular patients with diabetes from the phase 3 CARISA (n=189 with angina and diabetes) and MERLIN TIMI-36 (n=2,220 with acute coronary syndromes and diabetes) clinical trials.
In the CARISA (Combination Assessment of Ranolazine in Stable Angina) study, Ranexa reduced glycated hemoglobin (HbA1c) levels by an average of up to 0.